鼻咽癌放疗中容积旋转调强放疗摆位不确定性的计划稳健性剂量学评估
本研究纳入10例鼻咽癌患者,每例设计双弧容积旋转调强放疗计划,基于前5次锥形束CT摆位误差重算5个不确定性计划,评估计划稳健性并计算肿瘤控制概率与正常组织并发症概率。结果显示计划对摆位不确定性敏感,肿瘤欠剂量与邻近危及器官过剂量风险增加。
要点
- PTVp的ΔD98%和ΔD95%分别为3.30 Gy和2.02 Gy,CTVp为1.12 Gy和0.58 Gy。
- 双侧腮腺对摆位不确定性敏感,NTCP平均降低左侧6.17%、右侧7.70%。
- 作者提出一种评估VMAT计划稳健性的有效方法,光子放疗中应考虑计划稳健性与复杂性。
核心结论
- 鼻咽癌VMAT计划对摆位不确定性敏感性强,肿瘤欠剂量与邻近危及器官过剂量风险增加。
- 作者提出了一种评估VMAT计划稳健性的有效方法。
- 光子放疗中应考虑计划稳健性与复杂性。
研究设计与样本
- 选取10例患者,每例使用Varian Eclipse(13.6版本)治疗计划系统生成双弧VMAT计划。
- 基于锥形束CT获取的前5次摆位误差重算5个不确定性计划。
- 计算肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)进行生物学评估。
主要发现
- PTVp的ΔD98%和ΔD95%分别为3.30 Gy和2.02 Gy。
- CTVp的ΔD98%和ΔD95%分别为1.12 Gy和0.58 Gy;CTVn为1.39 Gy和1.03 Gy,明显低于PTVn的2.8 Gy和2.0 Gy。
- GTVp的ΔD98%和ΔD95%分别为0.56 Gy和0.33 Gy;GTVn的D98%变化0.64 Gy、D95%变化0.39 Gy,稳健性强。
- GTVp和CTVp的TCP平均降低分别为0.4%和0.3%;GTVn和CTVn的ΔTCP分别为0.92%和1.3%,CTV的ΔTCP最大为2.2%。
- 脑干因邻近PTV稳健性弱;双侧腮腺NTCP平均降低左侧6.17%、右侧7.70%;视神经和晶状体Dmax变化轻微。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the sensitivity to set up the uncertainty of VMAT plans in Nasopharyngeal carcinoma (NPC) treatment by proposing a plan robustness evaluation method. METHODS: 10 patients were selected for this study. A 2-arc volumetric-modulated arc therapy (VMAT) plan was generated for each patient using Varian Eclipse (13.6 Version) treatment planning system (TPS). 5 uncertainty plans (U-plans) were recalculated based on the first 5 times set-up errors acquired from cone-beam computer tomography (CBCT). The dose differences of the original plan and perturbed plan corresponded to the plan robustness for the structure. Tumor control probability (TCP) and normal tissues complication probability (NTCP) were calculated for biological evaluation. RESULTS: The mean dose differences of D98% and D95% (ΔD98% and ΔD95%) of PTVp were respectively 3.30 Gy and 2.02 Gy. The ΔD98% and ΔD95% of CTVp were 1.12 Gy and 0.58 Gy. The ΔD98% and ΔD95% of CTVn were 1.39 Gy and 1.03 Gy, distinctively lower than those in PTVn (2.8 Gy and 2.0 Gy). The CTV-to-PTV margin increased the robustness of CTVs. The ΔD98% and ΔD95% of GTVp were 0.56 Gy and 0.33 Gy. GTVn exhibited strong robustness with little variation of D98% (0.64 Gy) and D95% (0.39 Gy). No marked mean dose variations of Dmean were seen. The mean reduction of TCP (ΔTCP) in GTVp and CTVp were respectively 0.4% and 0.3%. The mean ΔTCPs of GTVn and CTVn were 0.92% and 1.3% respectively. The CTV exhibited the largest ΔTCP (2.2%). In OARs, the brain stem exhibited weak robustness due to their locations in the vicinity of PTV. Bilateral parotid glands were sensitive to set-up uncertainty with a mean reduction of NTCP (ΔNTCP) of 6.17% (left) and 7.70% (right). The Dmax of optical nerves and lens varied slightly. CONCLUSION: VMAT plans had a strong sensitivity to set-up uncertainty in NPC radiotherapy, with increasing risk of underdose of tumor and overdose of vicinal OARs. We proposed an effective method to evaluate the plan robustness of VMAT plans. Plan robustness and complexity should be taken into account in photon radiotherapy.
引用
- Ding Z, Xiang X, Zeng Q, et al. Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy. Radiat Oncol. 2022. PMID: 34980178. doi:10.1186/s13014-021-01970-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。